Databases on processes for R&D

Processes for R&D are activities in between inputs for and outputs of undertaking R&D that allows tracking what is being done by whom, on what, how. Examples include clinical trials registration, patents registration etc.

Health products in the pipeline

This “COVID-19 R&D tracker” developed by Policy Cures Research contains an interactive dashboard titled: The pipeline of COVID-19 therapeutics, vaccines and diagnostics” , which tracks products in the pipeline for COVID-19 globally since January 2020. Data can be explored by product type, developer and  R&D development stage.

This subscription database tracks drug profiles from discovery to market launch for all diseases. Each profile outlines the developmental stages for the diseases being investigated, the organizations involved in product development, important developmental milestones, and summarized results of scientific studies.

This is the main website for Foundation for Innovative New Diagnostics (FIND). It gives information on their portfolio for diagnostics, which includes hepatitis C, HIV, malaria, tuberculosis [TB] and neglected tropical diseases as well as various cross-cutting themes such as antimicrobial resistance (AMR) and pandemic preparedness (see their portfolio tab). Their tools and support tab give links to other useful resources and tools such as target product profiles, a diagnostics pipeline tracker (see further information below) and clinical trial platforms.

FIND diagnostics pipeline tracker

This is an interactive diagnostics pipeline developed by FIND that maps the status and estimated release dates of various diagnostics for the diseases tracked by FIND. The tracker allows stakeholders to visualize the diagnostic landscape and predict when products may be available for implementation. The pipeline can be viewed by status and by timeline.

This freely available database on drugs and drug targets combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. Its broad scope and detail lead to it claiming to be more like a drug encyclopedia than a drug database.

MMV, an antimalarial drug research and development product development partnership (PDP), provides a quarterly updated analysis on its website of candidate products in the global pipeline for malaria for medicines, vaccines and diagnostics (Vector control products are not included.)

The Pew Charitable Trusts is a non-profit nongovernmental organization based in the United States of America (USA). It has published a ‘snapshot’ of the current antibiotic pipeline, which is based on publicly available information and informed by an external expert. This focuses on antibiotics under development for the USA market and includes products containing at least one component not approved previously in the USA. Analyses are limited to systemic antibiotics and drugs to treat Clostridium difficile-associated disease. This pipeline analysis is also limited to drugs with the potential to treat serious or life-threatening infections (accurate as of December 2016).